KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Revenue: 2009-2025

Historic Revenue for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $11.1 billion.

  • Thermo Fisher Scientific's Revenue rose 4.94% to $11.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $43.7 billion, marking a year-over-year increase of 3.22%. This contributed to the annual value of $42.9 billion for FY2024, which is 0.05% up from last year.
  • Thermo Fisher Scientific's Revenue amounted to $11.1 billion in Q3 2025, which was up 2.46% from $10.9 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Revenue registered a high of $11.8 billion during Q2 2022, and its lowest value of $9.3 billion during Q3 2021.
  • For the 3-year period, Thermo Fisher Scientific's Revenue averaged around $10.7 billion, with its median value being $10.7 billion (2023).
  • Per our database at Business Quant, Thermo Fisher Scientific's Revenue soared by 59.00% in 2021 and then declined by 9.38% in 2023.
  • Thermo Fisher Scientific's Revenue (Quarterly) stood at $10.7 billion in 2021, then grew by 6.99% to $11.4 billion in 2022, then fell by 4.93% to $10.9 billion in 2023, then rose by 4.68% to $11.4 billion in 2024, then rose by 4.94% to $11.1 billion in 2025.
  • Its Revenue stands at $11.1 billion for Q3 2025, versus $10.9 billion for Q2 2025 and $10.4 billion for Q1 2025.